- Home
- PLRX vs CYH Comparison
PLRX vs CYH Comparison
Compare PLRX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | CYH |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | 60000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 440.5M |
| IPO Year | 2020 | 1991 |
Fundamental Metrics
Financial Performance| Metric | PLRX | CYH |
|---|---|---|
| Price | $1.23 | $3.13 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 7 |
| Target Price | ★ $3.79 | $3.73 |
| AVG Volume (30 Days) | ★ 1.9M | 1.5M |
| Earning Date | 11-06-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.47 |
| Revenue | N/A | ★ $12,644,000,000.00 |
| Revenue This Year | N/A | $0.04 |
| Revenue Next Year | N/A | $0.86 |
| P/E Ratio | ★ N/A | $1.29 |
| Revenue Growth | N/A | ★ 0.74 |
| 52 Week Low | $1.10 | $2.24 |
| 52 Week High | $13.71 | $4.47 |
Technical Indicators
Market Signals| Indicator | PLRX | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 39.36 |
| Support Level | $1.20 | $3.16 |
| Resistance Level | $1.27 | $3.25 |
| Average True Range (ATR) | 0.06 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 29.03 | 8.33 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.